cagrilintide semaglutide cagrisema phase 3 results 2024 2025 Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, study Dual Therapy CagriSema Promising for

Remember, these are general nutrition considerations to keep in mind while you are on a GLP-1 weight-loss medication

Clinical trials have shown that Vitamin C is gastroprotective and attenuates non-steroidal anti-inflammatory-drug-induced gastric damage

No government ID upload

In SUMMIT, tirzepatide reduced the composite of cardiovascular death or worsening heart-failure events by 38% (HR 0.62, 95% CI 0.410.95) and worsening HF events alone by 46% (HR 0.54, 95% CI 0.340.85), with a +6.9-point between-group improvement in the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS), an 18-meter improvement in 6-minute walk distance (6MWD), and a placebo-adjusted weight loss of 11.6% [5]

Those are not subtle numbers they represent one of the most significant topical anti-aging results measured by objective 3D imaging in cosmetic science

Monster Energy Drinks - 500ml Monster Energy is a sparkling sugar-free energy drink enriched with L-carnitine, taurine, and B vitamins